Medibank Private Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 2/6

Medibank Private 4.51% cari getiri oranına sahip temettü ödeyen bir şirkettir.

Anahtar bilgiler

4.5%

Temettü verimi

0.07%

Geri Alım Getirisi

Toplam Hissedar Getirisi	4.6%
Gelecekteki Temettü Verimi	5.1%
Temettü Büyümesi	2.0%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	AU$0.166
Ödeme oranı	11,723%

Son temettü ve geri alım güncellemeleri

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 09

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Aug 26

Recent updates

We Discuss Whether Medibank Private Limited's (ASX:MPL) CEO Is Due For A Pay Rise

Nov 15

With EPS Growth And More, Medibank Private (ASX:MPL) Makes An Interesting Case

Nov 01

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 09

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Aug 26

Medibank Private (ASX:MPL) Has Announced That It Will Be Increasing Its Dividend To A$0.073

Aug 21

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

May 29

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28

Does Medibank Private (ASX:MPL) Deserve A Spot On Your Watchlist?

Feb 27

Medibank Private's (ASX:MPL) Dividend Will Be Increased To AU$0.069

Aug 30

Are Dividend Investors Getting More Than They Bargained For With Medibank Private Limited's (ASX:MPL) Dividend?

Feb 14

Is Medibank Private Limited's (ASX:MPL) Recent Stock Performance Influenced By Its Financials In Any Way?

Jan 19

Did You Participate In Any Of Medibank Private's (ASX:MPL) Respectable 74% Return?

Dec 23

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Temettü ödemeleri istikrarlı olsa da MPL 10 yıldan az bir süredir temettü ödüyor.

Büyüyen Temettü: MPL şirketinin temettü ödemeleri artmış, ancak şirket yalnızca 9 yıldır temettü ödemiştir.

Piyasaya Karşı Temettü Getirisi

Medibank Private Piyasaya Karşı Temettü Getirisi

MPL temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (MPL)	4.5%
Pazarın Alt %25'i (AU)	2.6%
Pazarın En İyi %25'i (AU)	6.1%
Sektör Ortalaması (Insurance)	4.1%
Analist tahmini (MPL) (3 yıla kadar)	5.1%

Önemli Temettü: MPL 'in temettüsü ( 4.51% ), Australian piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 2.63% ) daha yüksektir.

Yüksek Temettü: MPL 'in temettüsü ( 4.51% ), Australian piyasasındaki temettü ödeyenlerin en üst %25'ine ( 6.11% ) kıyasla düşüktür.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Yüksek ödeme oranı ( 11723.2% ) nedeniyle MPL 'un temettü ödemeleri kazançlar tarafından yeterince karşılanmıyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Makul nakit ödeme oranı ( 56.4% ) ile MPL 'un temettü ödemeleri nakit akışları ile karşılanmaktadır.

Medibank Private Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 2/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Upcoming dividend of AU$0.073 per share

Recent updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

Full year 2024 earnings: EPS misses analyst expectations

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

Medibank Private Limited's (ASX:MPL) Prospects Need A Boost To Lift Shares

Here's Why Medibank Private (ASX:MPL) Has Caught The Eye Of Investors

High number of new directors

First half dividend increased to AU$0.072

New major risk - Revenue and earnings growth

First half 2024 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Medibank Private Limited (ASX:MPL) Investors Are Less Pessimistic Than Expected

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

We Discuss Whether Medibank Private Limited's (ASX:MPL) CEO Is Due For A Pay Rise

With EPS Growth And More, Medibank Private (ASX:MPL) Makes An Interesting Case

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Announces Class Action Filed in the Federal Court of Australia

Medibank Private Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued after recent price drop

Price target decreased to AU$3.36

Consensus EPS estimates fall by 10%

Price target decreased to AU$3.45

Investor sentiment deteriorated over the past week

Upcoming dividend of AU$0.073 per share

Medibank Private (ASX:MPL) Has Announced That It Will Be Increasing Its Dividend To A$0.073

Full year 2022 earnings: EPS and revenues miss analyst expectations

Medibank Private Limited Announces Distribution for the Six Months Ended June 30, 2022, Payable on September 29, 2022

Healius Reportedly Launches Day Surgery Sale Process

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

Medibank Private Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Independent Non-Executive Director recently bought AU$151k worth of stock

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Does Medibank Private (ASX:MPL) Deserve A Spot On Your Watchlist?

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Private Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2021, Payable on March 24, 2022

Medibank Private Limited Appoints Kathryn Fagg Ao and Peter Everingham as Non-Executive Directors Effective 31 March 2022

Now 22% undervalued after recent price drop

Upcoming dividend of AU$0.069 per share

Medibank Private's (ASX:MPL) Dividend Will Be Increased To AU$0.069

Medibank Private Limited Provides Earnings Guidance for 2022

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

CEO & Director Craig Drummond has left the company

First half 2021 earnings released: EPS AU$0.082 (vs AU$0.065 in 1H 2020)

Earnings beat expectations, revenue disappoints

Craig Drummond to Retire as Chief Executive Officer of Medibank Private Limited on 30 June 2021

New 90-day low: AU$2.79

Are Dividend Investors Getting More Than They Bargained For With Medibank Private Limited's (ASX:MPL) Dividend?

Medibank Private Limited (ASX:MPL) entered into share purchase agreement to acquire 49%stake in Myhealth Medical Holdings Pty Ltd from Crescent Capital Partners Management Pty Ltd and others for AUD 63 million.

Is Medibank Private Limited's (ASX:MPL) Recent Stock Performance Influenced By Its Financials In Any Way?

Did You Participate In Any Of Medibank Private's (ASX:MPL) Respectable 74% Return?

Medibank Private Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$3.04

New 90-day high: AU$2.90

New 90-day low - AU$2.49

Independent Non-Executive Director recently bought AU$115k worth of stock

New 90-day low - AU$2.73

Earnings released

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi